Skip to main content
Psyence Group Inc. logo

Psyence Group Inc. — Investor Relations & Filings

Ticker · PSYG ISIN · CA74449Q2053 LEI · 549300RPEOIVSD0MJC07 CSE Manufacturing
Open in API
Filings indexed 195 across all filing types
Latest filing 2023-08-28 Regulatory Filings
Country CA Canada
Listing CSE PSYG

About Psyence Group Inc.

https://psyence.com/

Psyence Group Inc. is a science-led life science biotechnology company focused on the research, cultivation, and production of natural psychedelics and nature-based compounds. The company develops innovative, safe, and effective solutions for mental health. Its core clinical division, Psyence Therapeutics (now part of Psyence Biomedical Ltd.), pioneers the use of natural psilocybin formulations and treatment protocols, primarily targeting anxiety and depression within the context of palliative care. Supporting this effort, the company operates one of the world's first federally licensed, ISO22000 certified psilocybin cultivation and production facilities. Furthermore, Psyence Function markets a range of non-psychoactive functional mushroom wellness products utilizing adaptogens.

Recent filings

Filing Released Lang Actions
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a certification by the CEO of Psyence Group Inc. regarding the interim financial report and interim MD&A for the period ended June 30, 2023. It is a Form 52-109FV2 Certification of Interim Filings for a Venture Issuer. The text primarily contains an officer's attestation about the accuracy and fair presentation of the interim filings, without including the actual financial data or substantive financial analysis. According to the Certification Rule, such certification documents should be classified as Regulatory Filings (RNS) rather than as the interim report itself (IR). The document length is relatively short (3062 characters), and it does not contain the interim financial statements or detailed financial analysis, only the certification of those filings. Therefore, the correct classification is Regulatory Filings (RNS).
2023-08-28 English
Interim MD&A - English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Management Discussion & Analysis (MD&A) for the three months ended June 30, 2023' and dated August 28, 2023. It contains detailed discussion of operations, business overview, corporate structure, financial information, risk factors, and forward-looking statements. The content includes substantive financial and operational analysis for a quarterly period, consistent with an Interim / Quarterly Report. The document is approximately 15,000 characters, indicating it is a full report rather than a brief announcement or certification. There is no indication that this is an Annual Report, Earnings Release, or other filing type. Therefore, the document fits the definition of an Interim / Quarterly Report (IR).
2023-08-28 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Unaudited Condensed Consolidated Interim Financial Statements For the three months ended June 30, 2023' and contains detailed financial statements including statements of financial position, net loss and comprehensive loss, changes in equity, cash flows, and notes to the financial statements. It explicitly states compliance with IAS 34 Interim Financial Reporting and is prepared on an interim basis for a three-month period ending June 30, 2023. The document is approximately 15,000 characters long, indicating it is a full report rather than a brief announcement. There is no indication that this is an annual report or a full year report, but rather a quarterly or interim report. Therefore, the document fits the definition of an Interim / Quarterly Report (IR).
2023-08-28 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is an announcement by Psyence Group Inc. regarding the closing of a private placement and the conclusion of a loan agreement. It details the issuance of shares, the amount raised, the use of proceeds, and terms of a loan agreement. There are no financial statements, quarterly or annual results, or detailed financial analysis present. The content focuses on fundraising activities and capital structure changes. Therefore, this document fits the category of Capital/Financing Update (CAP). The document length is 7135 characters, which is sufficient for a detailed announcement but does not contain financial report data. Hence, the classification is CAP with high confidence.
2023-08-21 English
Material change report - English.pdf
Capital/Financing Update Classification · 100% confidence The document is a Form 51-102F3 Material Change Report filed by Psyence Group Inc. It announces a private placement of shares and a secured loan agreement, detailing financing activities including share issuance and loan terms. The content focuses on capital raising and financing updates rather than financial results, management changes, or regulatory certifications. The document length is about 9,838 characters, which is substantive and contains detailed information about the financing event. Therefore, it fits best under the category for Capital/Financing Update (CAP).
2023-08-21 English
Material change report - English.pdf
Regulatory Filings Classification · 95% confidence The document is a Form 51-102F3 Material Change Report filed by Psyence Group Inc. It details a material change event involving a business combination agreement with a SPAC (Newcourt Acquisition Corp), including the filing of a registration statement on Form F-4 with the SEC. The content focuses on the announcement of this material change, the business combination agreement, and related regulatory filings. It is not a full financial report, audit, or earnings release, but rather a regulatory announcement of a significant corporate event. The document length is substantial (15,000 characters), and it contains detailed information about the material change, consistent with a Material Change Report under Canadian securities regulations. This type of filing is best classified under Regulatory Filings (RNS) as it is a general regulatory announcement and does not fit the other more specific categories such as M&A Activity or Proxy Solicitation, which would require the actual merger documents or proxy statements themselves. Therefore, the appropriate classification is Regulatory Filings (RNS).
2023-08-02 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.